デフォルト表紙
市場調査レポート
商品コード
1635820

在宅分子検査市場：世界の産業分析、市場規模・シェア・成長・動向、将来予測 (2025～2032年)

At-Home Molecular Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 221 Pages
納期
2～5営業日
カスタマイズ可能
在宅分子検査市場：世界の産業分析、市場規模・シェア・成長・動向、将来予測 (2025～2032年)
出版日: 2025年01月15日
発行: Persistence Market Research
ページ情報: 英文 221 Pages
納期: 2～5営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の在宅分子検査市場に関する広範なレポートを発行しました。当レポートでは、市場促進要因・動向・機会・課題などの主要な市場力学を包括的に分析し、市場構造に関する深い洞察を提供しています。

主要な洞察

  • 在宅分子検査の市場規模 (2025年)：118億米ドル
  • 市場規模の予測 (金額ベース、2032年)：178億米ドル
  • 世界市場の成長率 (CAGR、2025～2032年)：6.2%

在宅分子検査市場：分析範囲

在宅分子検査市場には、特定のバイオマーカー、病原体、遺伝的状態を検出するための検査を家庭で実施できるようにする様々な診断キットやソリューションが含まれます。これらの製品は、利便性、正確性、使いやすさを重視して設計されており、疾病診断、遺伝的素因検査、健康モニタリングなど、消費者の多様なニーズに対応しています。市場は、消費者直販チャネル、小売店、オンラインプラットフォーム、ヘルスケアプロバイダーなど、多様なセグメントにサービスを提供しています。成長の原動力は、便利で利用しやすい診断ソリューションに対する需要の高まり、分子検査における技術進歩、慢性疾患や感染症の有病率の上昇です。

市場成長の促進要因：

いくつかの重要な要因が、世界の在宅分子検査市場を牽引しています。予防ヘルスケアと早期疾病診断に対する意識の高まりが、在宅分子検査ソリューションの採用を後押ししています。ポリメラーゼ連鎖反応 (PCR) や等温増幅技術など、分子診断における技術の進歩は、ユーザーフレンドリーで正確な検査キットの開発を可能にしています。加えて、生活習慣病の有病率の増加と個別化医療に対する需要の高まりが、市場の拡大に拍車をかけています。研究開発活動の強化と検査形式やアプリケーションの革新は、多様な医療ニーズを持つ消費者に合わせたソリューションを提供することで、市場拡大にさらに貢献しています。

市場抑制要因：

有望な成長見通しにもかかわらず、在宅分子検査市場は、高度な診断キットの高コストや、特定の在宅検査の正確性や信頼性に関する懸念に関連する課題に直面しています。新興国市場における消費者の認知度の低さや、製品認可のための規制上のハードルは、市場の成長を妨げる可能性があります。さらに、分子検査プロセスの複雑さが、診断ツールに不慣れな消費者の採用を妨げる可能性もあります。これらの問題に対処するには、製品の革新、消費者教育、精度と手頃な価格を維持しながら検査手順を簡素化する取り組みへの継続的な投資が必要です。

市場機会：

市場は、在宅分子検査ソリューションとシームレスに統合する遠隔医療およびデジタルヘルスプラットフォームの採用拡大により、大きなビジネスチャンスをもたらしています。CRISPRベースの診断やポイントオブケア核酸検査などの先端技術の開発は、迅速かつ正確な結果を求めるニーズの高まりに対応しています。特にオンライン・チャネルを通じた販売網の拡大は、企業に幅広い市場リーチを提供し、エンドユーザーにとってのアクセシビリティを高める。ヘルスケアプロバイダーとの戦略的提携やデータセキュリティとプライバシーへの投資は、新たなビジネスチャンスを生かし、この進化する市場で消費者の信頼を維持するために不可欠です。

当レポートで回答する主な質問

  • 世界の在宅分子検査市場の成長を促進する主な要因は何か？
  • 異なる消費者層で採用をリードしている在宅分子検査の種類は何か？
  • 技術進歩は、在宅分子検査市場の競合情勢にどのような影響を与えているか？
  • 在宅分子検査市場の主要企業はどこか？また、競争力を維持するためにどのような戦略を採用しているのか？
  • 世界の在宅分子検査市場における新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主な動向
  • 製品のライフサイクル分析
  • 在宅分子検査市場：バリューチェーン
    • 原材料サプライヤー一覧
    • メーカー一覧
    • 販売代理店一覧
    • 用途一覧
    • 収益性分析
  • ポーターファイブフォースの分析
  • 地政学的緊張：市場への影響
  • マクロ経済要因
    • 世界の部門別の展望
    • 世界のGDP成長の見通し
    • 世界の親市場の概要
  • 予測要因：関連性と影響
  • 規制と技術の情勢

第3章 世界の在宅分子検査市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

  • 主なハイライト
    • 市場規模の予測 (数量ベース)
    • 市場規模と前年比成長率
    • 絶対的収益機会
  • 市場規模の分析と予測 (金額ベース (10億米ドル))
    • 過去の市場規模の分析 (2019～2023年)
    • 現在の市場規模の予測 (2025～2032年)
  • 世界の在宅分子検査市場の展望：製品別
    • イントロダクション/主な調査結果
    • 過去の市場規模の実績：製品別 (金額 (10億米ドル)・数量ベース、2019～2023年)
    • 現在の市場規模の予測：製品別 (金額 (10億米ドル)・数量ベース、2025～2032年)
      • カセット
      • ストリップ
      • テストパネル
      • ディップカード
      • ミッドストリーム
      • その他
  • 市場魅力分析：製品別
  • 世界の在宅分子検査市場の展望：検査の種類別
    • イントロダクション/主な調査結果
    • 過去の市場規模の実績：検査の種類別 (金額 (10億米ドル)・数量ベース、2019～2023年)
    • 現在の市場規模の予測：検査の種類別 (金額 (10億米ドル)・数量ベース、2025～2032年)
      • 妊娠検査
      • HIV検査
      • 糖尿病
      • 感染症
      • グルコース検査
      • 排卵予測検査
      • 薬物乱用検査
      • その他
  • 市場魅力分析：検査の種類別
  • 世界の在宅分子検査市場の展望：標本の種類別
    • イントロダクション/主な調査結果
    • 過去の市場規模の実績：標本の種類別 (金額 (10億米ドル)・数量ベース、2019～2023年)
    • 現在の市場規模の予測：標本の種類別 (金額 (10億米ドル)・数量ベース、2025～2032年)
      • 尿
      • 血
      • 唾液
      • その他
  • 市場魅力分析：標本の種類別
  • 世界の在宅分子検査市場の展望：流通チャネル別
    • イントロダクション/主な調査結果
    • 過去の市場規模の実績：流通チャネル別 (金額 (10億米ドル)・数量ベース、2019～2023年)
    • 現在の市場規模の予測：流通チャネル別 (金額 (10億米ドル)・数量ベース、2025～2032年)
      • 小売薬局
      • ドラッグストア
      • スーパーマーケット/ハイパーマーケット
      • オンライン薬局
  • 市場魅力分析：流通チャネル別

第4章 世界の在宅分子検査市場の展望：地域別

  • 主なハイライト
  • 過去の市場規模の分析：地域別 (金額 (10億米ドル)・数量ベース、2019～2023年)
  • 現在の市場規模の予測：地域別 (金額 (10億米ドル)・数量ベース、2025～2032年)
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析：地域別

第5章 北米の在宅分子検査市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第6章 欧州の在宅分子検査市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第7章 東アジアの在宅分子検査市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第8章 南アジア・オセアニアの在宅分子検査市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第9章 ラテンアメリカの在宅分子検査市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第10章 中東・アフリカの在宅分子検査市場の展望：過去 (2019～2023年) と予測 (2025～2032年)

第11章 競合情勢

  • 市場シェア分析 (2024年)
  • 市場構造
    • 競合激化マップ：市場別
    • 競合ダッシュボード
    • 製品の生産能力 (見かけ値)：製品別
  • 企業プロファイル (詳細：概要、財務、戦略、最近の動向)
    • Abbott
    • ACON Laboratories, Inc.
    • Rapikit
    • Becton and Dickinson
    • Cardinal Health
    • B. Braun Melsungen AG
    • Piramal Enterprises Ltd.
    • Siemens Healthcare GmbH
    • Quidel Corporation
    • Bionime Corporation
    • SA Scientific
    • ARKRAY USA, Inc.
    • Nova Biomedical
    • AdvaCare Pharma
    • AccuBioTech Co., Ltd.
    • Atlas Medical UK
    • TaiDoc Technology Corporation
    • Dragerwerk AG &Co. KGaA
    • F. Hoffmann-La Roche Ltd
    • Sensing Self
    • PTE. Ltd
    • Atomo Diagnostics
    • Mankind Pharma

第12章 付録

  • 分析手法
  • 分析の前提条件
  • 頭字語と略語
目次
Product Code: PMRREP33685

Persistence Market Research has recently published an extensive report on the global At-Home Molecular Testing Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • At-Home Molecular Testing Market Size (2025E): USD 11.8 Bn
  • Projected Market Value (2032F): USD 17.8 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.2%

At-Home Molecular Testing Market - Report Scope:

The At-Home Molecular Testing Market encompasses a range of diagnostic kits and solutions that allow individuals to perform tests at home for detecting specific biomarkers, pathogens, or genetic conditions. These products are designed for convenience, accuracy, and ease of use, catering to a wide variety of consumer needs, including disease diagnosis, genetic predisposition testing, and health monitoring. The market serves diverse segments, including direct-to-consumer channels, retail outlets, online platforms, and healthcare providers. Growth is driven by increasing demand for convenient and accessible diagnostic solutions, technological advancements in molecular testing, and the rising prevalence of chronic and infectious diseases.

Market Growth Drivers:

Several key factors are driving the global At-Home Molecular Testing Market. The rising awareness of preventive healthcare and early disease diagnosis is boosting the adoption of at-home molecular testing solutions. Technological advancements in molecular diagnostics, such as polymerase chain reaction (PCR) and isothermal amplification techniques, have enabled the development of user-friendly and accurate testing kits. Additionally, the increasing prevalence of lifestyle diseases, coupled with the growing demand for personalized medicine, is fueling market expansion. Enhanced research and development activities, along with innovations in test formats and applications, further contribute to market growth by offering tailored solutions for consumers with diverse healthcare needs.

Market Restraints:

Despite promising growth prospects, the At-Home Molecular Testing Market faces challenges related to the high costs of advanced diagnostic kits and concerns regarding the accuracy and reliability of certain at-home tests. Limited consumer awareness in developing regions and regulatory hurdles for product approval can hinder market growth. Additionally, the complexity of molecular testing processes may deter adoption among consumers unfamiliar with diagnostic tools. Addressing these issues requires continuous investment in product innovation, consumer education, and efforts to simplify test procedures while maintaining accuracy and affordability.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of telemedicine and digital health platforms, which integrate seamlessly with at-home molecular testing solutions. The development of advanced technologies, such as CRISPR-based diagnostics and point-of-care nucleic acid testing, caters to the growing need for rapid and accurate results. Expanding distribution networks, particularly through online channels, provides companies with broader market reach and enhances accessibility for end-users. Strategic collaborations with healthcare providers and investments in data security and privacy are essential for capitalizing on emerging opportunities and maintaining consumer trust in this evolving market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the At-Home Molecular Testing Market globally?
  • Which types of at-home molecular tests are leading adoption across different consumer segments?
  • How are technological advancements influencing the competitive landscape of the At-Home Molecular Testing Market?
  • Who are the key players in the At-Home Molecular Testing Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global At-Home Molecular Testing Market?

Competitive Intelligence and Business Strategy:

Leading players in the global At-Home Molecular Testing Market, including Abbott Laboratories, Thermo Fisher Scientific, and F. Hoffmann-La Roche AG, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, such as multiplexed tests and portable devices. Collaborations with telehealth providers, distributors, and e-commerce platforms facilitate market access and promote new product adoption. Emphasis on consumer education, high-quality products, and targeted marketing strategies fosters market growth and enhances brand loyalty in the dynamic At-Home Molecular Testing Market landscape.

Key Companies Profiled:

  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.

At-Home Molecular Testing Market Industry Segmentation:

By Product:

  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstream
  • Others

By Test Type:

  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others

By Sample Type:

  • Urine
  • Blood
  • Saliva
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global At-home Molecular Testing Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. At-home Molecular Testing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global At-home Molecular Testing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
      • 3.3.3.1. Cassettes
      • 3.3.3.2. Strips
      • 3.3.3.3. Test Panels
      • 3.3.3.4. Dip Cards
      • 3.3.3.5. Midstreams
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global At-home Molecular Testing Market Outlook: Test Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Test Type, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
      • 3.5.3.1. Pregnancy Tests
      • 3.5.3.2. HIV Tests
      • 3.5.3.3. Diabetes
      • 3.5.3.4. Infectious Diseases
      • 3.5.3.5. Glucose Tests
      • 3.5.3.6. Ovulation Predictor Tests
      • 3.5.3.7. Drug Abuse Tests
      • 3.5.3.8. Others
  • 3.6. Market Attractiveness Analysis: Test Type
  • 3.7. Global At-home Molecular Testing Market Outlook: Sample Type
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Sample Type, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
      • 3.7.3.1. Urine
      • 3.7.3.2. Blood
      • 3.7.3.3. Saliva
      • 3.7.3.4. Others
  • 3.8. Market Attractiveness Analysis: Sample Type
  • 3.9. Global At-home Molecular Testing Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
    • 3.9.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
      • 3.9.3.1. Retail Pharmacies
      • 3.9.3.2. Drug Stores
      • 3.9.3.3. Supermarkets/Hypermarkets
      • 3.9.3.4. Online Pharmacies
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global At-home Molecular Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Test Type
    • 5.3.4. By Sample Type
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 5.5.1. Cassettes
    • 5.5.2. Strips
    • 5.5.3. Test Panels
    • 5.5.4. Dip Cards
    • 5.5.5. Midstreams
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 5.6.1. Pregnancy Tests
    • 5.6.2. HIV Tests
    • 5.6.3. Diabetes
    • 5.6.4. Infectious Diseases
    • 5.6.5. Glucose Tests
    • 5.6.6. Ovulation Predictor Tests
    • 5.6.7. Drug Abuse Tests
    • 5.6.8. Others
  • 5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 5.7.1. Urine
    • 5.7.2. Blood
    • 5.7.3. Saliva
    • 5.7.4. Others
  • 5.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 5.8.1. Retail Pharmacies
    • 5.8.2. Drug Stores
    • 5.8.3. Supermarkets/Hypermarkets
    • 5.8.4. Online Pharmacies
  • 5.9. Market Attractiveness Analysis

6. Europe At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Test Type
    • 6.3.4. By Sample Type
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 6.5.1. Cassettes
    • 6.5.2. Strips
    • 6.5.3. Test Panels
    • 6.5.4. Dip Cards
    • 6.5.5. Midstreams
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 6.6.1. Pregnancy Tests
    • 6.6.2. HIV Tests
    • 6.6.3. Diabetes
    • 6.6.4. Infectious Diseases
    • 6.6.5. Glucose Tests
    • 6.6.6. Ovulation Predictor Tests
    • 6.6.7. Drug Abuse Tests
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 6.7.1. Urine
    • 6.7.2. Blood
    • 6.7.3. Saliva
    • 6.7.4. Others
  • 6.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 6.8.1. Retail Pharmacies
    • 6.8.2. Drug Stores
    • 6.8.3. Supermarkets/Hypermarkets
    • 6.8.4. Online Pharmacies
  • 6.9. Market Attractiveness Analysis

7. East Asia At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Test Type
    • 7.3.4. By Sample Type
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 7.5.1. Cassettes
    • 7.5.2. Strips
    • 7.5.3. Test Panels
    • 7.5.4. Dip Cards
    • 7.5.5. Midstreams
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 7.6.1. Pregnancy Tests
    • 7.6.2. HIV Tests
    • 7.6.3. Diabetes
    • 7.6.4. Infectious Diseases
    • 7.6.5. Glucose Tests
    • 7.6.6. Ovulation Predictor Tests
    • 7.6.7. Drug Abuse Tests
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 7.7.1. Urine
    • 7.7.2. Blood
    • 7.7.3. Saliva
    • 7.7.4. Others
  • 7.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Drug Stores
    • 7.8.3. Supermarkets/Hypermarkets
    • 7.8.4. Online Pharmacies
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Test Type
    • 8.3.4. By Sample Type
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 8.5.1. Cassettes
    • 8.5.2. Strips
    • 8.5.3. Test Panels
    • 8.5.4. Dip Cards
    • 8.5.5. Midstreams
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 8.6.1. Pregnancy Tests
    • 8.6.2. HIV Tests
    • 8.6.3. Diabetes
    • 8.6.4. Infectious Diseases
    • 8.6.5. Glucose Tests
    • 8.6.6. Ovulation Predictor Tests
    • 8.6.7. Drug Abuse Tests
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 8.7.1. Urine
    • 8.7.2. Blood
    • 8.7.3. Saliva
    • 8.7.4. Others
  • 8.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 8.8.1. Retail Pharmacies
    • 8.8.2. Drug Stores
    • 8.8.3. Supermarkets/Hypermarkets
    • 8.8.4. Online Pharmacies
  • 8.9. Market Attractiveness Analysis

9. Latin America At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Test Type
    • 9.3.4. By Sample Type
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 9.5.1. Cassettes
    • 9.5.2. Strips
    • 9.5.3. Test Panels
    • 9.5.4. Dip Cards
    • 9.5.5. Midstreams
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 9.6.1. Pregnancy Tests
    • 9.6.2. HIV Tests
    • 9.6.3. Diabetes
    • 9.6.4. Infectious Diseases
    • 9.6.5. Glucose Tests
    • 9.6.6. Ovulation Predictor Tests
    • 9.6.7. Drug Abuse Tests
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 9.7.1. Urine
    • 9.7.2. Blood
    • 9.7.3. Saliva
    • 9.7.4. Others
  • 9.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 9.8.1. Retail Pharmacies
    • 9.8.2. Drug Stores
    • 9.8.3. Supermarkets/Hypermarkets
    • 9.8.4. Online Pharmacies
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Test Type
    • 10.3.4. By Sample Type
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 10.5.1. Cassettes
    • 10.5.2. Strips
    • 10.5.3. Test Panels
    • 10.5.4. Dip Cards
    • 10.5.5. Midstreams
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 10.6.1. Pregnancy Tests
    • 10.6.2. HIV Tests
    • 10.6.3. Diabetes
    • 10.6.4. Infectious Diseases
    • 10.6.5. Glucose Tests
    • 10.6.6. Ovulation Predictor Tests
    • 10.6.7. Drug Abuse Tests
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 10.7.1. Urine
    • 10.7.2. Blood
    • 10.7.3. Saliva
    • 10.7.4. Others
  • 10.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 10.8.1. Retail Pharmacies
    • 10.8.2. Drug Stores
    • 10.8.3. Supermarkets/Hypermarkets
    • 10.8.4. Online Pharmacies
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. ACON Laboratories, Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Rapikit
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Becton and Dickinson
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Cardinal Health
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. B. Braun Melsungen AG
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Piramal Enterprises Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Siemens Healthcare GmbH
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Quidel Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bionime Corporation
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. SA Scientific
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. ARKRAY USA, Inc.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Nova Biomedical
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. AdvaCare Pharma
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. AccuBioTech Co., Ltd.
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy
    • 11.3.16. Atlas Medical UK
      • 11.3.16.1. Overview
      • 11.3.16.2. Segments and Product
      • 11.3.16.3. Key Financials
      • 11.3.16.4. Market Developments
      • 11.3.16.5. Market Strategy
    • 11.3.17. TaiDoc Technology Corporation
      • 11.3.17.1. Overview
      • 11.3.17.2. Segments and Product
      • 11.3.17.3. Key Financials
      • 11.3.17.4. Market Developments
      • 11.3.17.5. Market Strategy
    • 11.3.18. Dragerwerk AG & Co. KGaA
      • 11.3.18.1. Overview
      • 11.3.18.2. Segments and Product
      • 11.3.18.3. Key Financials
      • 11.3.18.4. Market Developments
      • 11.3.18.5. Market Strategy
    • 11.3.19. F. Hoffmann-La Roche Ltd
      • 11.3.19.1. Overview
      • 11.3.19.2. Segments and Product
      • 11.3.19.3. Key Financials
      • 11.3.19.4. Market Developments
      • 11.3.19.5. Market Strategy
    • 11.3.20. Sensing Self
      • 11.3.20.1. Overview
      • 11.3.20.2. Segments and Product
      • 11.3.20.3. Key Financials
      • 11.3.20.4. Market Developments
      • 11.3.20.5. Market Strategy
    • 11.3.21. PTE. Ltd
      • 11.3.21.1. Overview
      • 11.3.21.2. Segments and Product
      • 11.3.21.3. Key Financials
      • 11.3.21.4. Market Developments
      • 11.3.21.5. Market Strategy
    • 11.3.22. Atomo Diagnostics
      • 11.3.22.1. Overview
      • 11.3.22.2. Segments and Product
      • 11.3.22.3. Key Financials
      • 11.3.22.4. Market Developments
      • 11.3.22.5. Market Strategy
    • 11.3.23. Mankind Pharma
      • 11.3.23.1. Overview
      • 11.3.23.2. Segments and Product
      • 11.3.23.3. Key Financials
      • 11.3.23.4. Market Developments
      • 11.3.23.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations